Farmak discovers and delivers innovative medicines and solutions that enhance people’s lives.
We continually expand our market presence in well-regulated and emerging markets by developing and producing high-quality products and maintaining a robust business reputation.
Tablets Solution for Injection in oil
50mg, 100mg
100mg/mL: 3mL
Tablets
125mg, 250mg
Film-coated Tablets
2.5mg
5mg, 10mg
Farmak International is an oncology pharmaceuticals supplier. We focus on primary market segments, producing medicines that stimulate or suppress the immune system to inhibit tumour growth and treat other related conditions.
Developing our assortment, we combine products intended for targeted therapies. Our CTD-ready portfolio encompasses institutional cancer medications used as hormone therapy for hormone-dependent cancers. The mechanism of their action is based on blocking hormones from fueling cancer cell growth or reducing the production of the body’s hormones. We offer three classes from the category:
We are not a distributor of cytotoxic agents. Our generic oncology medications mostly block hormone receptors, which prevents the production of natural hormones (like estrogen or testosterone) that hormone-sensitive cancer cells need to grow.
As an immunomodulatory agent and generic oncology drug distributor, we deliver our products to pharmaceutical companies, distributors, hospitals, procurement organizations, and healthcare partners. Our oncology formulary products are widely used in hospital oncology departments, cancer treatment centres, antiandrogen supplier hospitals, and other specialised clinics.
We manufacture and supply EU GMP-certified medicines and prepare tender-ready dossiers for submission directly to global pharmacy procurement organisations for formulary inclusion. Also, we take part in tenders and compete for procurement contracts to handle oncology pharmacy supplies to European and global markets.
Our offering features medications with various physical designs. A route of administration impacts bioavailability, absorption speed, usability, and even shelf life. Some formulations of hormone therapy cancer medications are better for emergencies where immediate initiation of effect is crucial. Others are more convenient for a patient to take medication. We offer both tablets and solutions for injections in oil with diverse dosage strengths. Some tabs are film-coated to mask tastes, protect against moisture, and ensure easy swallowing. Medications are packaged in blisters and ampules to be stored according to the regulatory requirements to maintain stability.
As an antineoplastic drugs distributor, we broaden our reach in well-regulated markets by offering high-quality products that meet international standards. Quality is at the core of our business. To confirm this, we hold vital national and international approvals, including EU GMP certification.
Our GMP-certified manufacturing is highly regulated and sterile to ensure that cancer-fighting drugs are consistently produced and properly packaged.
To be a legal antiandrogen, hormone therapy, and aromatase inhibitors distributor, we are legally obligated to forward any adverse event reports, product complaints, or quality defects we receive from our partners directly to the Marketing Authorisation Holder. We perform pharmacovigilance and safety monitoring across the medical product lifecycle.
Thanks to a long-standing international reach as a cancer treatment medication supplier and our brand awareness, Farmak International ensures reliable availability of critical oncology medications. We offer competitive pricing possible due to initially favourable specialised rates and discounts that additionally can be negotiated with large healthcare buyers.
We prepare a comprehensive regulatory dossier that proves product safety, efficacy, and quality, including our GMP certificates and certificate of analysis, and a comprehensive product dossier containing chemistry, manufacturing, and controls (CMC) data. This set of documentation is sufficient to submit for participation in tenders. Also, we provide technical support for hospital pharmacies.
We can boast a market presence in Central and Eastern Europe, Central Asia, and the Middle East and North Africa, particularly in the UAE, where we meet the growing demand for high-quality medications.
This information is intended solely for healthcare professionals. Healthcare professionals must rely on their own professional clinical judgment when deciding whether to use a particular product for treating a specific patient. Farmak AG does not provide medical advice and recommends that healthcare professionals be appropriately trained in the use of any product before administering it. Healthcare professionals must always refer to the product's package insert, label, and/or instructions for use before application. The information provided is intended to illustrate Farmak AG's product portfolio and may vary depending on regulatory or medical practices in different markets. Please contact your local Farmak International representative for availability information about specific products in your area.
This page is designed exclusively for healthcare professionals. If you are not a healthcare professional, please return to our homepage for general information about Farmak International.
Please check your email inbox for our corporate materials.
Please fill all the fields marked by *